RUNX2 and Cowden disease: Our overexpression and inhibition experiments of RUNX proteins in human CD4+ T cells suggest that both the dosage and the unique functional properties of RUNX2 are critical, particularly in driving the inflammatory TRM_2 phenotype in the gut of CD patients.